BioPorto A/S (THOXF)
USD 0.29
(0.0%)
USD 0.29
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.28 Million DKK | -42.53% |
| 2022 | 7.44 Million DKK | -26.98% |
| 2021 | 10.2 Million DKK | 27.63% |
| 2020 | 7.99 Million DKK | 417.28% |
| 2019 | 1.54 Million DKK | 96.32% |
| 2018 | 787 Thousand DKK | 0.0% |
| 2017 | - DKK | -100.0% |
| 2016 | 40 Thousand DKK | -37.5% |
| 2015 | 64 Thousand DKK | -26.44% |
| 2014 | 87 Thousand DKK | -17.14% |
| 2013 | 105 Thousand DKK | 0.0% |
| 2012 | - DKK | -100.0% |
| 2011 | 12.18 Million DKK | 2.2% |
| 2010 | 11.92 Million DKK | 0.0% |
| 2009 | - DKK | 0.0% |
| 2008 | - DKK | 0.0% |
| 2007 | - DKK | 0.0% |
| 2006 | - DKK | 0.0% |
| 2005 | - DKK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.94 Million DKK | 0.0% |
| 2024 Q2 | 3.53 Million DKK | 0.0% |
| 2023 Q1 | 6.56 Million DKK | -11.84% |
| 2023 Q2 | 5.63 Million DKK | -14.18% |
| 2023 Q4 | 4.28 Million DKK | -12.46% |
| 2023 Q3 | 4.88 Million DKK | -13.24% |
| 2023 FY | 4.28 Million DKK | -42.53% |
| 2022 Q3 | 9.02 Million DKK | -2.55% |
| 2022 Q4 | 7.44 Million DKK | -17.43% |
| 2022 Q1 | 9.58 Million DKK | -6.05% |
| 2022 Q2 | 9.25 Million DKK | -3.41% |
| 2022 FY | 7.44 Million DKK | -26.98% |
| 2021 FY | 10.2 Million DKK | 27.63% |
| 2021 Q1 | 7.99 Million DKK | 0.05% |
| 2021 Q3 | 10.9 Million DKK | 40.82% |
| 2021 Q4 | 10.2 Million DKK | -6.46% |
| 2021 Q2 | 7.74 Million DKK | -3.16% |
| 2020 Q3 | 8.72 Million DKK | -8.95% |
| 2020 Q1 | 996 Thousand DKK | -35.53% |
| 2020 FY | 7.99 Million DKK | 417.28% |
| 2020 Q4 | 7.99 Million DKK | -8.37% |
| 2020 Q2 | 9.57 Million DKK | 861.75% |
| 2019 Q1 | 1.98 Million DKK | 0.0% |
| 2019 FY | 1.54 Million DKK | 96.32% |
| 2019 Q2 | 1.19 Million DKK | -39.9% |
| 2019 Q4 | 1.54 Million DKK | 158.36% |
| 2019 Q3 | 598 Thousand DKK | -49.87% |
| 2018 Q3 | - DKK | 0.0% |
| 2018 Q2 | - DKK | 0.0% |
| 2018 Q1 | - DKK | 0.0% |
| 2018 FY | 787 Thousand DKK | 0.0% |
| 2018 Q4 | - DKK | 0.0% |
| 2017 Q3 | - DKK | -100.0% |
| 2017 FY | - DKK | -100.0% |
| 2017 Q2 | 27 Thousand DKK | -20.59% |
| 2017 Q1 | 34 Thousand DKK | -15.0% |
| 2017 Q4 | - DKK | 0.0% |
| 2016 Q1 | 58 Thousand DKK | -9.38% |
| 2016 Q4 | 40 Thousand DKK | -13.04% |
| 2016 FY | 40 Thousand DKK | -37.5% |
| 2016 Q3 | 46 Thousand DKK | -11.54% |
| 2016 Q2 | 52 Thousand DKK | -10.34% |
| 2015 Q1 | 80 Thousand DKK | -8.05% |
| 2015 FY | 64 Thousand DKK | -26.44% |
| 2015 Q4 | 64 Thousand DKK | -8.57% |
| 2015 Q3 | 70 Thousand DKK | -6.67% |
| 2015 Q2 | 75 Thousand DKK | -6.25% |
| 2014 Q2 | 96 Thousand DKK | -4.95% |
| 2014 Q1 | 101 Thousand DKK | -3.81% |
| 2014 FY | 87 Thousand DKK | -17.14% |
| 2014 Q3 | 92 Thousand DKK | -4.17% |
| 2014 Q4 | 87 Thousand DKK | -5.43% |
| 2013 Q1 | - DKK | 0.0% |
| 2013 Q4 | 105 Thousand DKK | 0.0% |
| 2013 FY | 105 Thousand DKK | 0.0% |
| 2013 Q2 | - DKK | 0.0% |
| 2013 Q3 | - DKK | 0.0% |
| 2012 FY | - DKK | -100.0% |
| 2012 Q2 | 12.53 Million DKK | 1.42% |
| 2012 Q4 | - DKK | -100.0% |
| 2012 Q1 | 12.36 Million DKK | 1.45% |
| 2012 Q3 | 12.72 Million DKK | 1.48% |
| 2011 Q2 | 11.85 Million DKK | -1.94% |
| 2011 Q4 | 12.18 Million DKK | 1.44% |
| 2011 Q3 | 12.01 Million DKK | 1.35% |
| 2011 Q1 | 12.08 Million DKK | 1.38% |
| 2011 FY | 12.18 Million DKK | 2.2% |
| 2010 Q4 | 11.92 Million DKK | 1.33% |
| 2010 Q1 | - DKK | 0.0% |
| 2010 FY | 11.92 Million DKK | 0.0% |
| 2010 Q3 | 11.76 Million DKK | 0.0% |
| 2010 Q2 | - DKK | 0.0% |
| 2009 Q4 | - DKK | 0.0% |
| 2009 FY | - DKK | 0.0% |
| 2008 FY | - DKK | 0.0% |
| 2007 FY | - DKK | 0.0% |
| 2006 FY | - DKK | 0.0% |
| 2005 FY | - DKK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -71233.333% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -229.862% |
| Biocept, Inc. | 10.37 Million USD | 58.747% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 91.658% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 93.009% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -683.418% |
| iMD Companies, Inc. | 1.1 Million USD | -287.798% |
| IDenta Corp. | 428.17 Thousand USD | -899.589% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -0.872% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -1439.568% |
| NovelStem International Corp. | 3.32 Million USD | -28.737% |
| Optigenex Inc. | 4.42 Million USD | 3.322% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -162.416% |
| Response Genetics, Inc | 4.91 Million USD | 12.973% |
| Rennova Health, Inc. | 359.19 Thousand USD | -1091.56% |
| RushNet, Inc. | 4.25 Million USD | -0.649% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -1618.53% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -436.045% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -642.563% |
| Todos Medical Ltd. | 33 Million USD | 87.031% |